UMB Bank n.a. Has $7.11 Million Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

UMB Bank n.a. cut its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 29.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,956 shares of the biotechnology company’s stock after selling 5,055 shares during the period. UMB Bank n.a.’s holdings in Axon Enterprise were worth $7,106,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in the business. AHL Investment Management Inc. acquired a new position in Axon Enterprise during the 4th quarter valued at about $238,000. Trueblood Wealth Management LLC acquired a new position in Axon Enterprise during the 4th quarter valued at about $234,000. Artemis Investment Management LLP lifted its position in Axon Enterprise by 21.4% during the 4th quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after purchasing an additional 16,792 shares during the period. Oak Ridge Investments LLC lifted its position in Axon Enterprise by 5.4% during the 4th quarter. Oak Ridge Investments LLC now owns 15,153 shares of the biotechnology company’s stock valued at $9,006,000 after purchasing an additional 782 shares during the period. Finally, BNC Wealth Management LLC lifted its position in Axon Enterprise by 4.5% during the 4th quarter. BNC Wealth Management LLC now owns 10,849 shares of the biotechnology company’s stock valued at $6,448,000 after purchasing an additional 470 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on AXON. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Needham & Company LLC increased their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. The Goldman Sachs Group increased their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $504.92.

Axon Enterprise Price Performance

Shares of AXON opened at $593.89 on Monday. The stock has a market capitalization of $45.28 billion, a P/E ratio of 153.46, a P/E/G ratio of 5.71 and a beta of 1.04. Axon Enterprise, Inc. has a twelve month low of $247.04 and a twelve month high of $698.67. The company has a 50 day moving average of $617.37 and a 200-day moving average of $461.15. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the completion of the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last ninety days. 5.70% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.